Uscom Quarterly Report at 30th June 2020
Uscom Q4 FY20 4C Report
Uscom Q4 FY20 4C Presentation
"Uscom has delivered record growth in a rapidly shrinking commercial world. Medical technology is a cornerstone of health and investment, and Uscom continues to execute a targeted global strategy of growth and expansion.While the future is uncertain, China, Uscom’s major market, is rebounding, as Uscom is expanding into Europe and the US. Uscom has life saving devices in all the major global markets and a product pipeline to ensure revenue growth foreseeably. Uscom is becoming a global, vertically integrated Medical Technology leader."
Prof. Rob Phillips
Uscom has released its Appendix 4C - cash flow report for the quarter ending 30th June 2020.
Uscom reports continuing record growth in sales, receipts, profits and cash flow for the year, half and quarter. These results were achieved despite H1 hindered by a global restructure and re-organisation of operation, and H2 impaired by difficult global trading conditions.
Uscom reports continuing record growth in sales, receipts, profits and cash flow for the year, half and quarter. These results were achieved despite H1 hindered by a global restructure and re-organisation of operation, and H2 impaired by difficult global trading conditions.
- Annual cash receipts $4.6M - Up 36%
- H2 cash receipts of $3.0M delivers profitable & cash flow positive half
- Record results despite global restructure and pandemic
- New ventilator product set for global release